24 February 2010
GlaxoSmithKline responds to US Senate Committee on Finance report on Avandia
Julian Heslop, CFO, gave a presentation at the Cowen and Company 30th Annual Health Care Conference on 10 March 2010 in Boston. The presentation was attended by over 100 institutional investors and portfolio managers. Julian provided an overview of GSK's 2009 results and an outlook for the future.
We aim to create the best product pipeline in the industry for the benefit of patients, consumers and society.
Our R&D organisation measures productivity by the number and innovation of the products it creates, and also by the commercial value of the products.
Find out more about our pipeline